1. Meggiolaro, A., Unim, B., Semyonov, L., Miccoli, S., Maffongelli, E. & La Torre, G. The role of Pap test screening against cervical cancer: a systematic review and meta-analysis. Clin. Ter. 167, 124–139 (2016).
2. McGraw, S. L. & Ferrante, J. M. Update on prevention and screening of cervical cancer. World J. Clin. Oncol. 5, 744–752 (2014).
3. Koliopoulos, G., Nyaga, V. N., Santesso, N., Bryant, A., Martin-Hirsch, P. P., Mustafa, R. A. et al. Cytology versus HPV testing for cervical cancer screening in the general population. Cochrane Database Syst. Rev. 8, Cd008587 (2017).
4. Schiffman, M., Kinney, W. K., Cheung, L. C., Gage, J. C., Fetterman, B., Poitras, N. E. et al. Relative performance of HPV and cytology components of cotesting in cervical screening. J. Natl. Cancer Inst. 110, 501–508 (2017).
5. Silver, M. I., Rositch, A. F., Phelan-Emrick, D. F. & Gravitt, P. E. Uptake of HPV testing and extended cervical cancer screening intervals following cytology alone and Pap/HPV cotesting in women aged 30-65 years. Cancer Causes Control 29, 43–50 (2018).